OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma
Latha Dulipsingh, Danyal Ibrahim, Ernst J. Schaefer, et al.
Transfusion and Apheresis Science (2020) Vol. 59, Iss. 6, pp. 102922-102922
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
Vanessa Piechotta, Khai Li Chai, Sarah J Valk, et al.
Cochrane library (2020)
Open Access | Times Cited: 327

Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
Vanessa Piechotta, Claire Iannizzi, Khai Li Chai, et al.
Cochrane library (2021) Vol. 2021, Iss. 5
Open Access | Times Cited: 188

The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis
Stephen A. Klassen, Jonathon W. Senefeld, Patrick W. Johnson, et al.
Mayo Clinic Proceedings (2021) Vol. 96, Iss. 5, pp. 1262-1275
Open Access | Times Cited: 151

Convalescent plasma for people with COVID-19: a living systematic review
Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, et al.
Cochrane library (2023) Vol. 2024, Iss. 2
Closed Access | Times Cited: 34

Convalescent plasma for people with COVID-19: a living systematic review
Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, et al.
Cochrane library (2023) Vol. 2023, Iss. 2
Open Access | Times Cited: 31

Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update
Vivek P. Chavda, Rajashri Bezbaruah, Sheetal Dolia, et al.
Process Biochemistry (2023) Vol. 127, pp. 66-81
Open Access | Times Cited: 18

Anti–SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study
Evangelos Terpos, Marianna Politou, Theodoros Ν. Sergentanis, et al.
Microorganisms (2020) Vol. 8, Iss. 12, pp. 1885-1885
Open Access | Times Cited: 42

Prevalence and clinical relevance of viraemia in viral respiratory tract infections: a systematic review
Karl Hagman, Tamara Postigo, David Diez-Castro, et al.
The Lancet Microbe (2024), pp. 100967-100967
Open Access | Times Cited: 4

Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis
Henry T. Peng, Shawn G. Rhind, Andrew Beckett
JMIR Public Health and Surveillance (2021) Vol. 7, Iss. 4, pp. e25500-e25500
Open Access | Times Cited: 25

Prognostic and therapeutic potential of copper-induced cell death-related lncRNAs in lung squamous cell carcinoma
Zhe Tian, Lilan Cen, Haoming Hua, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access

Effect of time and titer in convalescent plasma therapy for COVID-19
Paola de Candia, Francesco Prattichizzo, S. Garavelli, et al.
iScience (2021) Vol. 24, Iss. 8, pp. 102898-102898
Open Access | Times Cited: 18

Correction: Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis
Henry T. Peng, Shawn G. Rhind, Andrew Beckett
JMIR Public Health and Surveillance (2021) Vol. 7, Iss. 6, pp. e31554-e31554
Open Access | Times Cited: 17

Time-dependent decay of detectable antibodies against SARS-CoV-2: A comparison of ELISA with two batches of a lateral-flow test
Mariângela Freitas da Silveira, Marília Arndt Mesenburg, Odir Antônio Dellagostin, et al.
The Brazilian Journal of Infectious Diseases (2021) Vol. 25, Iss. 4, pp. 101601-101601
Open Access | Times Cited: 11

Prospective Medicinal Plants and Their Phytochemicals Shielding Autoimmune and Cancer Patients Against the SARS-CoV-2 Pandemic: A Special Focus on Matcha
Caroline Joseph Kiriacos, Monika Rafik Khedr, Miray Tadros, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7

Association between convalescent plasma and the risk of mortality among patients with COVID-19: a meta-analysis
Shinta Oktya Wardhani, Jonny Karunia Fajar, Laksmi Wulandari, et al.
F1000Research (2021) Vol. 10, pp. 64-64
Open Access | Times Cited: 9

Corona Virus Disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging
Ernst J. Schaefer, Latha Dulipsingh, Florence Comite, et al.
PLoS ONE (2021) Vol. 16, Iss. 6, pp. e0252818-e0252818
Open Access | Times Cited: 9

Association between convalescent plasma and the risk of mortality among patients with COVID-19: a meta-analysis
Shinta Oktya Wardhani, Jonny Karunia Fajar, Laksmi Wulandari, et al.
F1000Research (2021) Vol. 10, pp. 64-64
Open Access | Times Cited: 8

Comparing SARS-CoV-2 neutralizing antibody levels in convalescent unvaccinated, convalescent vaccinated, and naive vaccinated subjects
Latha Dulipsingh, Ernst J. Schaefer, Dorothy Wakefield, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e17410-e17410
Open Access | Times Cited: 3

A Minimalist Strategy Towards Temporarily Defining Protection for COVID-19
Nevio Cimolai
SN Comprehensive Clinical Medicine (2020) Vol. 2, Iss. 11, pp. 2059-2066
Open Access | Times Cited: 8

Association between convalescent plasma and the risk of mortality among patients with COVID-19: a meta-analysis
Shinta Oktya Wardhani, Jonny Karunia Fajar, Laksmi Wulandari, et al.
F1000Research (2021) Vol. 10, pp. 64-64
Open Access | Times Cited: 6

Current advances in transfusion medicine 2020: A critical review of selected topics by the AABB Clinical Transfusion Medicine Committee
Elizabeth S. Allen, Claudia S. Cohn, Sara Bakhtary, et al.
Transfusion (2021) Vol. 61, Iss. 9, pp. 2756-2767
Open Access | Times Cited: 4

Investigation of Durability of SARS-CoV-2-specific IgG and IgM Antibodies in Recovered COVID-19 Patients: A Prospective Study
Mohammad Zamani, Ahmad Ghasemi, Morteza Shamshirgaran, et al.
Avicenna Journal of Medical Biotechnology (2022)
Open Access | Times Cited: 3

Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysis
Roberto Ariel Abeldaño Zúñiga, Ruth Ana María González Villoria, María Vanesa Elizondo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2

Clinical utility of Corona Virus Disease-19 serum IgG, IgM, and neutralizing antibodies and inflammatory markers
Ernst J. Schaefer, Florence Comite, Latha Dulipsingh, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2

Prevalence, Distribution and IgG Antibody Levels Associated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Health-System and Community-Based Employees and Patients
Edmond K. Kabagambe, Cruz Velasco‐Gonzalez, Marcia B. Henry, et al.
The American Journal of the Medical Sciences (2021) Vol. 363, Iss. 1, pp. 18-24
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top